{"prompt": "['Protocol Identifying Number: PS-001', 'Protocol Version: 1.0', 'Protocol Date: 10 Sep 2017', '69. Moretti S, Massi D, Farini V, et al. -adrenoceptors are upregulated in human melanoma and', 'their activation releases pro-tumorigenic cytokines and metalloproteases in melanoma cell lines.', 'Lab Invest. 2013; 93:279-90.', '70. Barbieri A, Bimonte S, Palma G, et al. Int J Oncol. 2015; 47:527-34. The stress hormone', 'norepinephrine increases migration of prostate cancer cells in vitro and in vivo. Int J Oncol.', '2015; 47:527-34.', '71. Thaivalappil S, Bauman N, Saieg A, et al. Propranolol-mediated attenuation of MMP-9 excretion', 'in infants with hemangiomas. JAMA Otolaryngol Head Neck Surg. 2013; 139:1026-31.', '72. Zhang J, Deng YT, Liu J, et al. Norepinephrine induced epithelial-mesenchymal transition in HT-', '29 and A549 cells in vitro. J Cancer Res Clin Oncol. 2016; 142:423-35.', '73. Wilson JM, Lorimer E, Tyburski MD, et al. \u00df-Adrenergic receptors suppress Rap1B prenylation', 'and promote the metastatic phenotype in breast cancer cells. Cancer Biol Ther. 2015; 16:1364-', '74.', '74. Campbell JP, Karolak MR, Ma Y, et al. Stimulation of host bone marrow stromal cells by', 'sympathetic nerves promotes breast cancer bone metastasis in mice. PLoS Biol. 2012;', '10:e1001363.', '75. Wolter JK, Wolter NE, Blanch A, et al. Anti-tumor activity of the beta-adrenergic receptor', 'antagonist propranolol in neuroblastoma. Oncotarget. 2014; 5:161-72.', '76. Wolter NE, Wolter JK, Enepekides DJ, et al. Propranolol as a novel adjunctive treatment for head', 'and neck squamous cell carcinoma. J Otolaryngol Head Neck Surg. 2012; 41:334-44.', '77. Albi\u00f1ana V, Villar G\u00f3mez de Las Heras K, Serrano-Heras G, et al. Propranolol reduces viability', 'and induces apoptosis in hemangioblastoma cells from von Hippel-Lindau patients. Orphanet J', 'Rare Dis. 2015; 10:118.', '78. Thaker PH, Han LY, Kamat AA, et al. Chronic stress promotes tumor growth and angiogenesis in a', 'mouse model of ovarian carcinoma. Nat Med. 2006; 12:939-44.', '79. Annabi B, Lachambre MP, Plouffe K, et al. Propranolol adrenergic blockade inhibits human brain', 'endothelial cells tubulogenesis and matrix metalloproteinase-9 secretion. Pharmacol Res. 2009;', '60:438-45.', '80. Park SY, Kang JH, Jeong KJ, et al. Norepinephrine induces VEGF expression and angiogenesis by', 'a', 'hypoxia-inducible factor-1a protein-dependent mechanism. Int J Cancer. 2011; 128:2306-16.', '81. Ramu A, Spanier R, Rahamimoff H, et al. Restoration of doxorubicin responsiveness in', 'doxorubicin-resistant P388 murine leukaemia cells. Br J Cancer. 1984; 50:501-7.', '82. Pasquier E, Ciccolini J, Carre M, et al. Propranolol potentiates the anti-angiogenic effects and', 'anti-tumor efficacy of chemotherapy agents: implication in breast cancer treatment.', 'Oncotarget. 2011; 2:797-809.', '83. Kanemi O, Zhang X, Sakamoto Y, et al. Acute stress reduces intraparenchymal lung natural killer', 'cells via beta-adrenergic stimulation. Clin Exp Immunol. 2005; 139:25-34.', '84. Kalinichenko VV, Mokyr MB, Graf LH Jr, et al. Norepinephrine-mediated inhibition of antitumor', 'cytotoxic T lymphocyte generation involves a beta-adrenergic receptor mechanism and', 'decreased TNF-alpha gene expression. J Immunol. 1999; 163:2492-9.', '85. Khalili A, Hassan ZM, Shahabi S, et al. Long acting propranolol and HSP-70 rich tumor lysate', 'reduce tumor growth and enhance immune response against fibrosarcoma in Balb/c mice. Iran', 'J', 'Immunol. 2013; 10:70-82.', 'Page 46 of 60']['Protocol Identifying Number: PS-001', 'Protocol Version: 1.0', 'Protocol Date: 10 Sep 2017', '86. Chang PY, Huang WY, Lin CL, et al. Propranolol Reduces Cancer Risk: A Population-Based Cohort', 'Study. Medicine (Baltimore). 2015; 94:e1097.', '87. Nkontchou G, Aout M, Mahmoudi A, et al. Effect of long-term propranolol treatment on', 'hepatocellular carcinoma incidence in patients with HCV-associated cirrhosis. Cancer Prev Res', '(Phila). 2012; 5:1007-14.', '88. Barron TI, Connolly RM, Sharp L, et al. Beta blockers and breast cancer mortality: a population-', 'based study. J Clin Oncol. 2011; 29:2635-44.', '89. Pasquier E, Andr\u00e9 N, Street J, et al. Effective Management of Advanced Angiosarcoma by the', 'Synergistic Combination of Propranolol and Vinblastine-based Metronomic Chemotherapy: A', 'Bench to Bedside Study. EBioMedicine. 2016; 6:87-95.', '90. Bhattacharyya GS, Ranade A, Malhotra H, et al. Continuous metronomic temozolamide with', 'propranolol and etodolac in recurrent globlastoma: A pilot study. J Clin Oncol. 2014; 32 suppl;', 'abstr e13005.', '91. Bhattacharyya GS, Babu KG, Bondarde SA, et al. Effect of coadministered beta blocker and COX-', '2 inhibitor to patients with pancreatic cancer prior to receiving albumin-bound (Nab) paclitaxel.', 'J Clin Oncol. 2015; 33 suppl 3; abstr 302.', '92. Lindgren ME, Fagundes CP, Alfano CM, et al. Beta-blockers may reduce intrusive thoughts in', 'newly diagnosed cancer patients. Psychooncology. 2013; 22:1889-94.', '93. Sethuraman G, Yenamandra VK, Gupta V. Management of infantile hemangiomas: current', 'trends. J Cutan Aesthet Surg. 2014; 7:75-85.', '94. Drolet BA, Frommelt PC, Chamlin SL, et al. Initiation and use of propranolol for infantile', 'hemangioma: report of a consensus conference. Pediatrics. 2013; 131:128-40.', '95. Hogeling M, Adams S, Wargon O. A randomized controlled trial of propranolol for infantile', 'hemangiomas. Pediatrics. 2011; 128:e259-66.', '96. Deng GH, Liu J, Zhang J, et al. Exogenous norepinephrine attenuates the efficacy of sunitinib in a', 'mouse cancer model. J Exp Clin Cancer Res. 2014; 33:21.', '97. Liu J, Deng GH, Zhang J, et al. The effect of chronic stress on anti-angiogenesis of sunitinib in', 'colorectal cancer models. Psychoneuroendocrinology 2015; 52:130-42.', '98. Xie J, Liu C. Adjusted Kaplan-Meier estimator and log-rank test with inverse probability of', 'treatment weighting for survival data. Stat Med. 2005; 24:3089-110.', 'Page 47 of 60']\n\n###\n\n", "completion": "END"}